The FDA has accepted an investigational new drug application for an investigational and proprietary combination therapy to ...
News-Medical.Net on MSN
COVID-19 immunity stays specific and barely boosts protection against common cold coronaviruses
This study shows that SARS-CoV-2 infection and vaccination generate strong, highly specific spike-binding immune responses ...
Robust target engagement was observed, with statistically significant increases in regulatory T-cell (Treg) suppressive function and Treg numbers beginning as early as two weeks post-dosing and ...
The FDA approval of denileukin diftitox (Lymphir) marked a significant shift in this paradigm. As a first-in-class immunotoxin, it employs a dual-action mechanism: directly targeting interleukin-2 (IL ...
The interferon regulatory factor (IRF) family of transcription factors, pivotal for initiating antiviral type I interferon ...
Under normal conditions, cytokines aid in pathogen recognition and elimination while contributing to immune system ...
As of Thursday, January 08, Corvus Pharmaceuticals, Inc.’s CRVS share price has dipped by 6.45%, which has investors ...
In a world where the immune system can be both hero and villain, three scientists have illuminated the path to taming its excesses. On October 6, 2025, ...
New research co-led by Indiana University School of Medicine scientists has exposed a vulnerability in acute myeloid leukemia ...
A recent study published in the journal Breast Cancer Research has found that adolescent girls who engage in regular organised physical activity show favourable changes in breast tissue composition ...
Shanghai Henlius Biotech, Inc. announced that it entered into an exclusive global license agreement with U-mab Biopharma ...
A new study published in the Journal of the European Academy of Dermatology & Venerology showed that in children with severe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results